Additionally, analysis based on 1,018 Chinese glioma patients suggested that CELF5 (P < 0.001), GSG1L (P = 0.002), AMACR (P < 0.001), CYP27A1 (P < 0.001), CYP46A1 (P < 0.001), and CH25H (P = 0.046) were all prognostic indicators in Kaplan-Meier survival analysis (Figures 9A–F). This evidence concerns the gene CYP46A1 and glioma.